Wael Zrafi

6PUBLICATIONS
122CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.

|Jul 13, 2026
Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung Cancer.

|Oct 22, 2024
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Filippo G Dall'Olio, Wael Zrafi, Veronique Roelants

|May 26, 2023
Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study.

Raoul C Reulen, David L Winter, Ibrahim Diallo

|Jun 17, 2021
Topographic variability of the normal circle of Willis anatomy on a paediatric population.

Wael Zrafi, Cristina Veres, Volodia Dangouloff-Ros

|Oct 09, 2020
Risk Factors of Subsequent Central Nervous System Tumors after Childhood and Adolescent Cancers: Findings from the French Childhood Cancer Survivor Study.

Neige Marie Yvanne Journy, Wael Salem Zrafi, Stéphanie Bolle

Pageof 1

Frequent Collaborators

3 joint publications

Benjamin Besse

2 joint publications

Daniel Gautheret

2 joint publications

Filippo G Dall'Olio

2 joint publications

Rodrigue Setcheou Allodji